CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Grant or award SVP & Chief Financial Officer acquired 28,750 shares (grant or award)
- 4 Grant or award SVP Pharma Dev & Mfg Ops acquired 18,500 shares (grant or award)
- 4 Grant or award SVP & Chief Scientific Officer acquired 23,950 shares (grant or award)
- 4 Open-market sale SVP & Chief Accounting Officer sold 4,016 shares at $38.25 ($153,612)
- 4 Open-market sale President & CEO sold 15,326 shares at $38.25 ($586,220)
- 4 Open-market sale SVP & Chief Operating Officer sold 5,982 shares at $38.25 ($228,812)
- 4 Open-market sale SVP & Chief Financial Officer sold 6,515 shares at $38.25 ($249,199)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 4,694 shares at $38.25 ($179,546)
- 4 Open-market sale SVP & Chief Scientific Officer sold 4,524 shares at $38.25 ($173,043)
- 4 Grant or award SVP & Chief Accounting Officer acquired 90,000 shares (grant or award)
- 4 Grant or award Director acquired 4,750 shares (grant or award)
- 4 Grant or award Director acquired 4,750 shares (grant or award)
- 4 Grant or award Director acquired 4,750 shares (grant or award)
- 4 Grant or award Director acquired 4,750 shares (grant or award)
- 4 Grant or award Director acquired 4,750 shares (grant or award)
- 4 Grant or award Director acquired 4,750 shares (grant or award)
- 4 Grant or award Director acquired 8,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 9,000 shares at $56.98 ($512,820)
- 4 Open-market sale Director sold 4,500 shares at $56.81 ($255,645)
Page 16 of 49 · 970 filings